Expert Q&A: OneLab—Pathology Meets Virtual Reality
CDC Virtual Reality Training lead Joe Rothschild discusses the new OneLab VR initiative—and the future of this project for the clinical lab
Keep up to date on new and emerging diagnostic tests, testing trends and opportunities, and disruptive technologies
CDC Virtual Reality Training lead Joe Rothschild discusses the new OneLab VR initiative—and the future of this project for the clinical lab
In early May, GSK’s Arexvy became the first RSV vaccine to be cleared by the FDA for use in the US in adults aged 60 and up.
AAV2 virus detected with metagenomics, TE sequencing, and PCR in non-A–E hepatitis cases from two cohorts in Scotland/the UK and the US.
A simple blood test may help screen, identify, intervene, treat, monitor, and eventually, prevent PTSD.
New research suggests that the call to rein in low-value prostate cancer screening seems to be falling on deaf ears.
Health inequities and disrupted STI testing and care during the pandemic continued to contribute to a rise in cases in 2021.
Though there are currently no clinical guidelines for their use, PRSs are being widely used in health care.
Recently released NGS systems will be helpful to researchers but are unlikely to immediately impact diagnostics, expert says.
New document aims to help clinicians navigate screening guidelines, choose testing strategies, and analyze test results.
On March 27, the agency released a new guidance document to help test developers make the transition to full approval.
The inexpensive POC device is a biosensor that performs COMT genotyping as a biomarker for hypnotizability.